The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus.
de Boer
R A
RA
Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. r.a.de.boer@thorax.umcg.nl
Martens
F M A C
FM
Kuipers
I
I
Boomsma
F
F
Visseren
F L J
FL
D000450:Aldosterone / Q000097:blood; D006631:Amine Oxidase (Copper-Containing) / Q000502:physiology; D009320:Atrial Natriuretic Factor / Q000097:blood; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D016232:Endothelins / Q000097:blood; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D047495:PPAR gamma / Q000819:agonists*; D000077205:Pioglitazone; D012083:Renin / Q000097:blood; D045162:Thiazolidinediones / Q000494:pharmacology*
D016232:Endothelins; D007004:Hypoglycemic Agents; D047495:PPAR gamma; D045162:Thiazolidinediones; D000450:Aldosterone; D009320:Atrial Natriuretic Factor; D006631:Amine Oxidase (Copper-Containing); D012083:Renin; D000077205:Pioglitazone